Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 28/11/2011
PIL Zyban 150 mg prolonged release film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 21/03/2011 and displayed until 28/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 06/01/2011 and displayed until 21/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 11/03/2010 and displayed until 06/01/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change due to user-testing of patient information
Updated on 14/05/2009 and displayed until 11/03/2010
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to date of revision
Updated on 05/03/2009 and displayed until 14/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
Updated on 07/11/2008 and displayed until 05/03/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 27/10/2006 and displayed until 07/11/2008
Reasons for adding or updating:
  • Change to drug interactions
Updated on 14/02/2006 and displayed until 27/10/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 04/09/2003 and displayed until 14/02/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 11/06/2002 and displayed until 04/09/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 08/05/2002 and displayed until 11/06/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 13/07/2001 and displayed until 08/05/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 09/04/2001 and displayed until 13/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 07/12/2000 and displayed until 09/04/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  bupropion hydrochloride